Carelabs Co.Ltd (263700) - Net Assets
Based on the latest financial reports, Carelabs Co.Ltd (263700) has net assets worth ₩78.32 Billion KRW (≈ $53.08 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩105.15 Billion ≈ $71.26 Million USD) and total liabilities (₩26.83 Billion ≈ $18.19 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Carelabs Co.Ltd (263700) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩78.32 Billion |
| % of Total Assets | 74.48% |
| Annual Growth Rate | 21.2% |
| 5-Year Change | -50.59% |
| 10-Year Change | N/A |
| Growth Volatility | 65.84 |
Carelabs Co.Ltd - Net Assets Trend (2016–2024)
This chart illustrates how Carelabs Co.Ltd's net assets have evolved over time, based on quarterly financial data. Also explore Carelabs Co.Ltd asset portfolio for the complete picture of this company's asset base.
Annual Net Assets for Carelabs Co.Ltd (2016–2024)
The table below shows the annual net assets of Carelabs Co.Ltd from 2016 to 2024. For live valuation and market cap data, see 263700 company net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩48.44 Billion ≈ $32.83 Million |
-29.31% |
| 2023-12-31 | ₩68.53 Billion ≈ $46.44 Million |
-19.00% |
| 2022-12-31 | ₩84.61 Billion ≈ $57.34 Million |
-17.29% |
| 2021-12-31 | ₩102.30 Billion ≈ $69.33 Million |
+4.33% |
| 2020-12-31 | ₩98.05 Billion ≈ $66.45 Million |
+57.51% |
| 2019-12-31 | ₩62.25 Billion ≈ $42.19 Million |
+4.20% |
| 2018-12-31 | ₩59.74 Billion ≈ $40.49 Million |
+154.58% |
| 2017-12-31 | ₩23.47 Billion ≈ $15.90 Million |
+125.57% |
| 2016-12-31 | ₩10.40 Billion ≈ $7.05 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Carelabs Co.Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1623.9% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩9.80 Billion | 20.24% |
| Other Components | ₩95.44 Billion | 197.00% |
| Total Equity | ₩48.44 Billion | 100.00% |
Carelabs Co.Ltd Competitors by Market Cap
The table below lists competitors of Carelabs Co.Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Westport Fuel Systems Inc
TO:WPRT
|
$34.79 Million |
|
TNR Gold Corp.
V:TNR
|
$34.79 Million |
|
Dabomb Protein
TWO:6578
|
$34.79 Million |
|
Display Tech Co. Ltd
KQ:066670
|
$34.81 Million |
|
Nam Hwa Construction Co.Ltd
KQ:091590
|
$34.77 Million |
|
Apollomics Inc. Class A Ordinary Shares
NASDAQ:APLM
|
$34.77 Million |
|
Digitalx Ltd
AU:DCC
|
$34.76 Million |
|
HWA AG
F:H9W
|
$34.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Carelabs Co.Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 68,531,506,170 to 48,443,567,680, a change of -20,087,938,490 (-29.3%).
- Net loss of 20,280,045,060 reduced equity.
- Dividend payments of 490,000,000 reduced retained earnings.
- Share repurchases of 44,000,000 reduced equity.
- Other factors increased equity by 726,106,570.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-20.28 Billion | -41.86% |
| Dividends Paid | ₩490.00 Million | -1.01% |
| Share Repurchases | ₩44.00 Million | -0.09% |
| Other Changes | ₩726.11 Million | +1.5% |
| Total Change | ₩- | -29.31% |
Book Value vs Market Value Analysis
This analysis compares Carelabs Co.Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.06x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 2.20x to 1.06x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1199.85 | ₩2645.00 | x |
| 2017-12-31 | ₩2529.66 | ₩2645.00 | x |
| 2018-12-31 | ₩4842.70 | ₩2645.00 | x |
| 2019-12-31 | ₩4898.78 | ₩2645.00 | x |
| 2020-12-31 | ₩5688.89 | ₩2645.00 | x |
| 2021-12-31 | ₩5935.22 | ₩2645.00 | x |
| 2022-12-31 | ₩4644.84 | ₩2645.00 | x |
| 2023-12-31 | ₩3532.56 | ₩2645.00 | x |
| 2024-12-31 | ₩2497.09 | ₩2645.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Carelabs Co.Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -41.86%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.38%
- • Asset Turnover: 0.58x
- • Equity Multiplier: 2.96x
- Recent ROE (-41.86%) is below the historical average (-6.33%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 18.59% | 10.40% | 1.17x | 1.52x | ₩894.14 Million |
| 2017 | 20.40% | 12.17% | 0.99x | 1.70x | ₩2.44 Billion |
| 2018 | 5.95% | 6.54% | 0.44x | 2.09x | ₩-2.42 Billion |
| 2019 | 0.94% | 0.85% | 0.54x | 2.04x | ₩-5.64 Billion |
| 2020 | 4.42% | 5.65% | 0.58x | 1.35x | ₩-5.48 Billion |
| 2021 | 1.22% | 1.33% | 0.47x | 1.94x | ₩-8.98 Billion |
| 2022 | -30.88% | -29.82% | 0.48x | 2.14x | ₩-34.58 Billion |
| 2023 | -35.71% | -29.90% | 0.50x | 2.37x | ₩-31.32 Billion |
| 2024 | -41.86% | -24.38% | 0.58x | 2.96x | ₩-25.12 Billion |
Industry Comparison
This section compares Carelabs Co.Ltd's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $34,094,274,688
- Average return on equity (ROE) among peers: -38.14%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Carelabs Co.Ltd (263700) | ₩78.32 Billion | 18.59% | 0.34x | $34.77 Million |
| BIT Computer Co. Ltd (032850) | $54.66 Billion | 11.84% | 0.29x | $57.69 Million |
| ezCaretech Co. LTD (099750) | $41.51 Billion | -2.39% | 0.41x | $158.32 Million |
| SyntekaBio Inc (226330) | $31.23 Billion | -36.50% | 0.69x | $39.21 Million |
| LifeSemantics Corp. (347700) | $8.98 Billion | -125.50% | 1.12x | $1.01 Billion |
About Carelabs Co.Ltd
Carelabs Co.,Ltd operates as a healthcare and beauty care platform company in South Korea. The company offers healthcare IT services, such as hospital information services, hospital customer management software, and digital marketing solutions. It provides BABITALK, a plastic surgery information platform; Medijob, which provides human resources to hospitals; VIBE RC, a digital marketing platform;… Read more